Barr Pharmaceuticals, Inc.
Letter of intent signed to acquire Mircette
Published in Medicine and Law Weekly, October 14th, 2005
Barr Pharmaceuticals, Inc., (BRL), Organon USA, Inc., and Organon (Ireland), Ltd., business units of Akzo Nobel NV (AKZOY), and Savient Pharmaceuticals, Inc., (SVNTE) confirmed that Barr Pharmaceuticals, Inc., and its subsidiaries have entered into a non-binding letter of intent to acquire the exclusive rights to Organon's Mircette (Desogestrel/Ethinyl Estradiol) oral contraceptive product.
The companies also agreed to settle the pending patent litigation with Organon and Savient concerning Barr Laboratories, Inc.'s generic version of Mircette, which the company markets under the trade name Kariva.
The parties also confirmed that they have requested,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Albany Molecular Research, Inc.
Chemistry-based drug discovery firm adds three people to management team - Alnylam Pharmaceuticals, Inc.
Intellectual property licensed for MicroRNA gene involved in hepatitis C - Avitar, Inc.
U.S. patent secured for oral fluid DNA test - Bioheart, Inc.
Two U.S. patents allowed regarding delivery systems - Competitive Technologies, Inc.
Carolina Liquid sued for patent infringement - Duke University, Durham
HIV-1 env clones developed for vaccine-elicited neutralizing antibody assessment - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
